Search & Analyze

Global Health Ltd.

1,265.00−34.20 (−2.63%)

BSE · 30 Oct, 4:01 PM

: ₹34,121.90 Cr
: 61.35
: 4,60,115
: ₹1,304.90 - ₹1,260.50
: ₹1,542.00 - ₹955.20

Global Health Ltd. (MEDANTA) share price closed at ₹1,265.00 on the BSE on Friday, October 30, 2026, down by 2.63% from its of ₹1,299.20. In that session MEDANTA reached a of 1,304.90 and of 1,260.50. The for the session was 1,279.18. The stands at 1,377.80 and is at 1,243.57. Looking at , the stock ended the session in Downtrend.

Stock Overview

₹1,303.80

₹1,299.20

₹1,279.18

₹1,377.80

Price 8.19% below

₹1,243.57

Price 1.72% above

Key Fundamentals

: 34,121.90 Cr₹34.12 Thousand Crore
: 20.69
: 61.35
: 8.30
: 152.93
: 1,079.17 Cr₹1.08 Thousand Crore
: 0.04 %
Sector
Industry: Hospital & Healthcare Services
: 15.12
: 0.16

Industry Comparison

Ratio	Company	Sector
	61.35	44.77
	0.16	0.20
	8.30	4.61
	2.67	1.81
	0.04 %	0.11 %
Operating Margin	20.96 %	19.15 %

Sector figures are the median of 154 listed Healthcare companies.

Peer Comparison

Name
APOLLO HOSP. APOLLOHOSP	8,400.00	57.80	1,20,779.11	0.24	610.40	38.41%	7,043.50	20.56%	21.73
MANIPALHOS MANIPALHOS	668.45	98.54	87,926.39	0.00	243.43	-4.18%	3,090.63	38.12%	13.93
MAXHEALTH MAXHEALTH	860.00	60.63	83,706.13	0.23	414.45	-15.64%	2,569.21	20.31%	14.97
ASTERDM ASTERDM	680.40	186.93	59,308.59	0.44	29.28	-68.70%	1,310.68	21.60%	16.22
FORTIS FORTIS	769.80	55.46	58,116.68	0.13	272.80	2.26%	2,545.03	17.46%	14.07
NH NH	1,700.00	43.06	34,741.34	0.26	301.15	16.50%	2,843.99	73.01%	16.20
Global Health Ltd. MEDANTA	1,265.00	61.35	34,121.90	0.04	157.25	-1.09%	1,304.05	26.50%	19.38
LALPATHLAB LALPATHLAB	1,892.90	59.05	31,772.10	1.08	170.50	27.24%	797.70	19.10%	29.56

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	808.63	861.08	956.56	943.44	931.25	1,030.84	1,099.22	1,121.05	1,159.05	1,304.05
Expenses	629.28	674.76	728.27	705.67	706.56	803.85	868.28	903.75	915.28	1,017.30
	179.35	186.32	228.29	237.77	224.69	226.99	230.94	217.30	243.76	286.75
	22.18%	21.64%	23.87%	25.20%	24.13%	22.02%	21.01%	19.38%	21.03%	21.99%
	27.42	21.93	18.22	16.02	-26.97	40.04	35.71	-14.82	36.74	22.16
Interest	18.23	17.98	15.98	16.28	15.03	13.79	17.11	21.51	26.71	26.68
	45.45	46.62	49.43	48.45	49.25	45.11	49.73	61.19	66.52	68.98
	143.09	143.65	181.10	189.07	133.44	208.14	199.81	119.78	187.28	213.26
	11.00%	26.03%	27.76%	24.44%	24.03%	23.62%	20.73%	20.66%	24.36%	26.26%
	127.38	106.29	130.84	142.91	101.40	159.01	158.44	95.02	143.99	158.73
	4.74	3.96	4.87	5.32	3.78	5.92	5.89	3.54	5.36	5.91

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
INCOME:
Operating Income	2,167.30	2,709.88	3,275.11	3,692.35	4,410.27
Operating Income (Net)	2,167.30	2,709.88	3,275.11	3,692.35	4,410.27
EXPENDITURE :
Increase/Decrease in Stock	-2.82	-1.58	-2.29	-2.75	-2.63
Cost of Medicines and Consumables	535.79	616.82	761.65	882.42	999.43
Power & Fuel Cost	47.06	57.12	59.91	62.00	68.15
Employee Cost	567.96	635.65	732.89	822.41	1,093.76
Hospital Operation Expenses	358.73	422.07	560.63	653.26	845.00
Selling, Administration and Other Expenses	188.27	266.49	303.03	359.11	450.21
Miscellaneous Expenses	14.24	77.06	50.35	55.46	32.13
	1,709.22	2,073.63	2,466.17	2,831.90	3,486.05
Operating Profit (Excl OI)	458.08	636.25	808.94	860.44	924.22
	38.52	49.29	74.66	104.81	104.41
	496.59	685.53	883.61	965.25	1,028.63
Interest	86.32	86.33	83.78	74.35	90.05
PBDT	410.27	599.21	799.83	890.90	938.58
	129.71	149.92	172.73	193.75	222.54
Profit Before Taxation & Exceptional Items	280.56	449.29	627.10	697.15	716.04
Exceptional Income / Expenses				-49.90	-1.02
	280.56	449.29	627.10	647.26	715.02
Provision for Tax	84.36	123.21	149.04	165.94	160.95
	196.20	326.08	478.06	481.32	554.07
Extra items				0.00	0.00
Minority Interest			0.13	0.12	2.39
Consolidated Net Profit	196.20	326.08	478.19	481.44	556.46
Profit Balance B/F	768.98	952.96	1,283.79	1,764.38	2,248.48
Appropriations	965.18	1,279.04	1,761.98	2,245.82	2,804.94
Equity Dividend %				25.00%	25.00%
	7.75	12.16	17.81	17.92	20.71
Adjusted EPS	7.75	12.16	17.81	17.92	20.71

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	50.64	53.64	53.70	53.72	53.74
Share Warrants & Outstandings	5.52	5.14	4.39	0.25	16.36
Total Reserves	1,559.84	2,369.43	2,847.54	3,332.44	3,891.48
Reserve excluding Revaluation Reserve	1,559.84	2,369.43	2,847.54	3,332.44	3,891.48
Revaluation reserve		0.00
	1,616.01	2,428.21	2,905.63	3,386.41	3,961.57
Minority Interest			-0.03	1.10	22.71
Secured Loans	717.17	659.47	235.96	264.10	601.12
Unsecured Loans	50.46	77.65	47.51
Deferred Tax Assets / Liabilities	-27.79	-6.90	-37.17	-33.02	-15.65
Other Long Term Liabilities	291.30	305.24	415.38	429.64	578.56
Long Term Provisions	555.12	54.04	57.74	66.17	113.92
Total Non-Current Liabilities	1,586.27	1,089.49	719.43	726.88	1,277.95
Trade Payables	134.33	194.69	186.78	194.81	242.37
Other Current Liabilities	265.84	352.09	394.48	376.61	354.77
Short Term Provisions	19.31	25.78	36.48	47.40	29.99
Total Current Liabilities	419.48	572.56	617.73	618.82	627.13
Total Liabilities	3,621.75	4,090.26	4,242.75	4,733.21	5,889.36
Gross Block	2,457.99	2,877.28	3,145.64	3,604.50	5,077.27
Less: Accumulated Depreciation	682.13	827.19	909.73	1,090.50	1,282.51
	1,775.86	2,050.09	2,235.91	2,514.01	3,794.76
	439.25	326.98	386.28	528.52	132.21
Non Current Investments	0.05	0.05	0.05	2.71	2.55
Long Term Investment	0.05	0.05	0.05	2.71	2.55
Long Term Loans & Advances	583.22	99.61	92.87	119.88	143.80
Other Non Current Assets	11.64	34.05	17.65	30.15	140.97
Total Non-Current Assets	2,810.03	2,510.77	2,734.02	3,200.08	4,214.44
Inventories	53.39	60.37	66.85	67.14	78.98
Sundry Debtors	180.20	194.20	215.31	291.86	411.19
Cash and Bank	511.81	1,278.10	1,175.28	1,122.34	1,130.23
Other Current Assets	46.10	18.99	17.18	23.81	18.60
Short Term Loans and Advances	20.23	27.82	34.11	27.98	35.93
Total Current Assets	811.73	1,579.49	1,508.73	1,533.12	1,674.92
Net Current Assets (Including Current Investments)	392.24	1,006.93	891.00	914.31	1,047.79
Total Assets	3,621.75	4,090.26	4,242.75	4,733.21	5,889.36
	23.79	46.70	52.32	88.77	100.01
Total Debt	837.86	842.22	419.34	327.88	631.08
	63.60	90.35	108.05	126.07	146.83
Adjusted Book Value	63.60	90.35	108.05	126.07	146.83

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
	280.56	449.29	627.10	647.26	715.02
Adjustment	195.49	198.55	208.36	240.44	204.01
Changes In working Capital	-66.77	102.82	-45.91	-99.71	-85.22
Cash Flow after changes in Working Capital	409.28	750.66	789.55	788.00	833.81
Cash Flow from Operating Activities	311.26	644.52	612.08	623.76	714.39
Cash Flow from Investing Activities	-420.88	-342.35	-440.80	-720.94	-1,089.11
Cash Flow from Financing Activitie	159.59	345.64	-513.92	-97.23	271.85
Net Cash Inflow / Outflow	49.97	647.81	-342.64	-194.41	-102.87
Opening Cash & Cash Equivalents	69.47	119.43	767.24	424.61	230.20
Closing Cash & Cash Equivalent	119.43	767.24	424.61	230.20	127.33

Ratios

Valuation

61.35

8.30

31.16

7.29

20.69

152.93

Profitability

15.12

19.38

10.43

20.96

12.56

Leverage & Liquidity

0.16

2.67

8.94

Returns

0.04

0.83

Shareholding Pattern

Numbers in percentages

Particulars	Jun '24	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26	Sep '26
	33.04	33.04	33.03	33.03	33.01	33.01	33.01	33.01	33.00	33.00
	23.51	23.31	22.98	23.69	23.74	24.38	24.53	24.91	26.35	26.92
	43.44	43.65	43.98	43.28	43.25	42.61	42.46	42.08	40.65	40.08
	66.96	66.96	66.97	66.97	66.99	66.99	66.99	67.00	67.00	67.00
No. of Shareholders	1,55,307	1,49,722	1,48,633	1,54,688	1,56,372	1,55,806	1,51,241	1,47,390	1,40,531	1,35,371

Mutual Funds Invested(153)

Based on each fund's latest monthly portfolio · Sep 2026

A total of 90 active funds hold 15.80% in Global Health Ltd., contributing to ₹5.80K Cr of holdings

Fund				As of
KO Kotak Mid Cap Fund - Growth - Direct PlanMid Cap Fund	1,212.57	1.82	88,83,314	Sep '26
IN Invesco India Midcap Fund - Growth - Direct PlanMid Cap Fund	624.81	3.97	45,77,395	Sep '26
UT UTI Flexi Cap Fund - Growth - Direct PlanFlexi Cap Fund	448.79	2.00	32,87,867	Sep '26
IN Invesco India Smallcap Fund - Growth - Direct PlanSmall cap Fund	299.50	1.86	21,94,163	Sep '26
IN Invesco India Contra Fund - Growth - Direct PlanEquity - Contra Fund	286.92	1.49	21,02,004	Sep '26
IN Invesco India Focused Fund - Growth - Direct PlanEquity - Focused Fund	233.74	3.75	17,12,376	Sep '26
IN Invesco India Large & Mid Cap Fund - Growth - Direct PlanLarge & Mid Cap	232.63	1.91	17,04,265	Sep '26
CR Canara Robeco Small Cap Fund - Growth - Direct PlanSmall cap Fund	232.27	1.66	17,01,593	Sep '26
CR Canara Robeco Large and Mid Cap Fund - Growth - Direct PlanLarge & Mid Cap	207.76	0.85	15,22,049	Sep '26
HD HDFC Multi Cap Fund - Growth - Direct PlanMulti Cap Fund	153.56	0.79	11,25,000	Sep '26

Corporate Actions

Showing: All

Date	Type	Details
2026-10-22	Board Meeting	Quarterly Results
2026-08-21	AGM
2026-07-20	Board Meeting	Quarterly Results

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)

No insider trading data available.

Sector Overview

HealthcareHospital & Healthcare Services

Global Health Ltd. operates in the Healthcare sector under the Hospital & Healthcare Services industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

11 members across the board and senior leadership

Rahul Ranjan

Company Secretary & Compliance Officer

—

Naresh Trehan

Chairman & Managing Director

₹7.19 Cr

Mar '26

Hari Shanker Bhartia

Non Executive Independent Director

₹27.00 L

Mar '26

Praveen Mahajan

Non Executive Independent Director

₹42.00 L

Mar '26

Rajan Bharti Mittal

Non Executive Independent Director

₹36.00 L

Mar '26

Ravi Gupta

Non Executive Independent Director

₹41.00 L

Mar '26

Ravi Kant Jaipuria

Nominee Director

—

Vikram Singh Mehta

Non Executive Independent Director

₹43.00 L

Mar '26

Pankaj Prakash Sahni

Whole Time Director & Chief Executive Officer

₹5.24 Cr

Mar '26

Shonan Purie Trehan

Non Independent & Non Executive Director

—

Sunil Sachdeva

Non Independent & Non Executive Director

—

MEDANTA Latest News

News

5 of 5 articles

COMPANY29 Sept 2026 · 15:47

Global Health acquires 10,560 sq. metres land parcel in Ghaziabad

The land parcel has been allotted for around Rs 165.82 crore on a freehold basis through an online auction conducted by UPAVP

EQUITY18 Jun 2026 · 17:22

Global Health informs about analyst meet

COMPANY12 Jun 2026 · 16:00

Global Health gets LoI from Government of Haryana

The LoI is for establishment of a Medical College with 150 MBBS seats at Medanta -The Medicity

EQUITY14 May 2026 · 16:49

Global Health reports Profit after tax of Rs 1241.31 Mln, in the March 2026 quarter

EQUITY11 May 2026 · 14:19

Global Health informs about updates

Global Health Ltd.

Stock Overview

Price chart

Peer Comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Valuation

Profitability

Leverage & Liquidity

Returns

Shareholding Pattern

Mutual Funds Invested(153)

Corporate Actions

Insider Trading

Sector Overview

Company Profile

Key Management

MEDANTA Latest News

News